Amy C. Peterson, CMO, Immuno-oncology at BeiGene, Ltd. (BGNE), sold 7,838 shares at $167.54 ($1.3M) on 2018-08-23, disclosed to the SEC on 2018-08-24.
Open-market sale of $1.3M BGNE by CMO, Immuno-oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.54 | 1,108 | $186K | 14.0% |
| 2 | $167.54 | 1,108 | $186K | 14.0% |
| 3 | $168.94 | 2,300 | $389K | 29.3% |
| 4 | $169.75 | 1,400 | $238K | 17.9% |
| 5 | $170.46 | 961 | $164K | 12.4% |
| 6 | $170.46 | 961 |
| $164K |
| 12.4% |
| Total | $169.06 avg | 7,838 | $1.3M | 100% |
| Filing → |
| CTMX | SELL | 2022-07-21 | $11K | — | Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-11-13 | $8.8M | — | Filing → |